Economic Analysis of Carboplatin Versus Cisplatin in Lung and Ovarian Cancer
Year of publication: |
1999
|
---|---|
Authors: | Khan, Zeba M. ; Rascati, Karen L. ; Koeller, Jim M. |
Published in: |
PharmacoEconomics. - Springer Healthcare | Adis, ISSN 1170-7690. - Vol. 16.1999, 1, p. 43-57
|
Publisher: |
Springer Healthcare | Adis |
Subject: | Ovarian-cancer | Carboplatin | Cisplatin | Non-small-cell-lung-cancer | Small-cell-lung-cancer | Cost-minimisation | Antineoplastics |
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
-
Chemotherapy Administration: Modelling the Costs of Alternative Protocols
Haywood, Philip, (2012)
-
Bongers, Mathilda L., (2012)
-
Vinorelbine in Advanced Non-Small Cell Lung Cancer: A Pharmacoeconomic Review
Coukell, Allan J., (1999)
- More ...
-
Returns to society from investment in cancer research and development
Chandra, Amitabh, (2016)
-
Quantifying gains in the war on cancer due to improved treatment and earlier detection
Seabury, Seth A., (2016)
-
Expanded newborn screening in Texas : a cost-effectiveness analysis using Markov modeling
Rascati, Karen L., (2009)
- More ...